» Articles » PMID: 12907738

Characterisation of the Substrate Specificity of Homogeneous Vaccinia Virus Uracil-DNA Glycosylase

Overview
Specialty Biochemistry
Date 2003 Aug 9
PMID 12907738
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The decision to stop smallpox vaccination and the loss of specific immunity in a large proportion of the population could jeopardise world health due to the possibility of a natural or provoked re-emergence of smallpox. Therefore, it is mandatory to improve the current capability to prevent or treat such infections. The DNA repair protein uracil-DNA glycosylase (UNG) is one of the viral enzymes important for poxvirus pathogenesis. Consequently, the inhibition of UNG could be a rational strategy for the treatment of infections with poxviruses. In order to develop inhibitor assays for UNG, as a first step, we have characterised the recombinant vaccinia virus UNG (vUNG) and compared it with the human nuclear form (hUNG2) and catalytic fragment (hUNG) UNG. In contrast to hUNG2, vUNG is strongly inhibited in the presence of 7.5 mM MgCl(2). We have shown that highly purified vUNG is not inhibited by a specific uracil-DNA glycosylase inhibitor. Interestingly, both viral and human enzymes preferentially excise uracil when it is opposite to cytosine. The present study provides the basis for the design of specific inhibitors for vUNG.

Citing Articles

Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity.

Serrano-Benitez A, Wells S, Drummond-Clarke L, Russo L, Thomas J, Leal G EMBO J. 2023; 42(18):e113190.

PMID: 37492888 PMC: 10505916. DOI: 10.15252/embj.2022113190.


Correlated Target Search by Vaccinia Virus Uracil-DNA Glycosylase, a DNA Repair Enzyme and a Processivity Factor of Viral Replication Machinery.

Diatlova E, Mechetin G, Yudkina A, Zharkov V, Torgasheva N, Endutkin A Int J Mol Sci. 2023; 24(11).

PMID: 37298065 PMC: 10253040. DOI: 10.3390/ijms24119113.


A New Class of Uracil-DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme.

Grin I, Mechetin G, Kasymov R, Diatlova E, Yudkina A, Shchelkunov S Molecules. 2021; 26(21).

PMID: 34771075 PMC: 8587785. DOI: 10.3390/molecules26216668.


Displacement of Slow-Turnover DNA Glycosylases by Molecular Traffic on DNA.

Yudkina A, Endutkin A, Diatlova E, Moor N, Vokhtantsev I, Grin I Genes (Basel). 2020; 11(8).

PMID: 32751599 PMC: 7465369. DOI: 10.3390/genes11080866.


Aberrant repair initiated by the adenine-DNA glycosylase does not play a role in UV-induced mutagenesis in .

Zutterling C, Mursalimov A, Talhaoui I, Koshenov Z, Akishev Z, Bissenbaev A PeerJ. 2018; 6:e6029.

PMID: 30568855 PMC: 6286661. DOI: 10.7717/peerj.6029.


References
1.
Holzer G, Falkner F . Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line. J Virol. 1997; 71(7):4997-5002. PMC: 191732. DOI: 10.1128/JVI.71.7.4997-5002.1997. View

2.
Nilsen H, Otterlei M, Haug T, Solum K, Nagelhus T, Skorpen F . Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res. 1997; 25(4):750-5. PMC: 146498. DOI: 10.1093/nar/25.4.750. View

3.
Reddy S, Williams M, Cohen J . Expression of a uracil DNA glycosylase (UNG) inhibitor in mammalian cells: varicella-zoster virus can replicate in vitro in the absence of detectable UNG activity. Virology. 1998; 251(2):393-401. DOI: 10.1006/viro.1998.9428. View

4.
Henderson D, INGLESBY T, Bartlett J, Ascher M, Eitzen E, Jahrling P . Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. 1999; 281(22):2127-37. DOI: 10.1001/jama.281.22.2127. View

5.
Otterlei M, Warbrick E, Nagelhus T, Haug T, Slupphaug G, Akbari M . Post-replicative base excision repair in replication foci. EMBO J. 1999; 18(13):3834-44. PMC: 1171460. DOI: 10.1093/emboj/18.13.3834. View